Sensex Finishes Firm Post Q3 GDP Data; Tata Steel Surges 3.7%

Wed, 1 Mar Closing

   Previous Close   

   Pre-Open   

   09:30 am   

   11:30 am   

   01:30 pm   

Share markets in India continued the rally and headed for a firm close on positive GDP data for the December quarter and favorable Asian cues. At the closing bell, the BSE Sensex closed higher by 241 points, whereas the NSE Nifty finished higher by 66 points. The S&P BSE Midcap finished up by 0.1% while the S&P BSE Small Cap ended up by 0.5%. Sectoral indices ended the day on a mixed note with power stocks and energy stocks leading the losses. While, realty and metal stocks were among the top gainers on the BSE.

Asian equity markets finished broadly higher today with shares in Japan leading the region. The Nikkei 225 was up 1.44% while China's Shanghai Composite ended up 0.16% and Hong Kong's Hang Seng was up 0.15%. European markets are higher today with shares in Germany leading the region. The DAX is up 1.38% while France's CAC 40 is up 1.25% and London's FTSE 100 is up 0.87%.

The rupee was trading at Rs 66.84 against the US$ in the afternoon session. Oil prices were trading at US$ 54.21 at the time of writing.

Steel stocks ended the day on a firm note with Tata Sponge and Jindal Saw being the most active stocks in this space. Tata steel share price continued the rally and finished up by 3.7% after it was reported that the company's recently commissioned Ferro-chrome plant at Gopalpur Industrial Park in Ganjam district of Odisha commenced production.

In November 2016, the company had inaugurated the ferrochrome plant in Gopalpur industrial park in Odisha. As part of the anchor investment in Tata Steel's Gopalpur Industrial Park, the Rs 5.42 billion Ferro-chrome plant has an installed capacity of 55,000 tonne per annum (tpa).

Ferrochrome is an alloy of chromium and iron containing 50% to 70% chromium by weight. It is a unique environment friendly plant with hi-tech pollution control equipment and technology such as ETP (effluent treatment plant) and STP (sewage treatment plant). It is the first plant in India to use briquetting method of chrome ore fines agglomeration.

Besides the new unit at Gopalpur, Tata Steel has two other such plants in Odisha under the management of its subsidiary TS Alloys.

To know more about the company's financial performance, subscribers can access to Tata Steel's latest result analysis (Subscription Required) and Tata steel stock analysis on our website.

Moving on to the news from stocks in pharma sector. According to a report by The Hindu Business Line, in spite of prevailing challenges in the Indian pharma sector is expected to grow up to 45% by 2025 and 58,000 additional job opportunities are likely to be created in the industry.

Despite the capping of prices, notebandi and GST implementation, all of which are perceived to impact the pharma sector adversely (subscription required), the industry will continue to grow. The major growth engines will be domestic sales, exports, an ageing population, health insurance coverage, increase in per capita spending, medical tourism etc., the reports noted.

Indian Pharma Revenue Growth Accelerates

In fact, by 2020, the pharma market will be touching US$ 55 billion with a CAGR of about 15.9%, with generics occupying 70% market share followed by over-the-counter 21% and patented drugs capturing 9% market share.

Reportedly, Biosimilars and Biologics are burgeoning sectors in 2017 also major scientific and technological advances, coupled with socio-demographic changes and increasing demand for medicines will revive the Indian pharma industry's fortunes for another 10 to 20 years.

But given the complexity of biologics, will Indian companies be able to break some ground in this space? A premium edition of The 5 Minute Wrap up offers a view on the same (subscription Required).

Meanwhile, we also wrote about the USFDA crackdowns faced by the Indian Pharma in the recent times and how they have been constantly investing towards R&D. We believe pharma companies that are upgrading and keeping facilities compliant, and have niche product pipelines in place will see sustained revenue growth going forward.

Pharma stocks ended the day on a mixed note with Panacea Biotech and Elder Pharma leading the gains.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers